165 related articles for article (PubMed ID: 22286807)
1. Cholinesterases, a target of pharmacology and toxicology.
Pohanka M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):219-29. PubMed ID: 22286807
[TBL] [Abstract][Full Text] [Related]
2. Nature: a substantial source of auspicious substances with acetylcholinesterase inhibitory action.
Orhan IE
Curr Neuropharmacol; 2013 Jul; 11(4):379-87. PubMed ID: 24381529
[TBL] [Abstract][Full Text] [Related]
3. Open Meter Duo: Low-Cost Instrument for Fluorimetric Determination of Cholinesterase Activity.
Keresteš O; Mozo JD; Pohanka M
Sensors (Basel); 2024 Mar; 24(6):. PubMed ID: 38544037
[TBL] [Abstract][Full Text] [Related]
4. New paradigms in the study of the cholinergic system and metabolic diseases: Acetyl-and-butyrylcholinesterase.
Villeda-González JD; Gómez-Olivares JL; Baiza-Gutman LA
J Cell Physiol; 2024 Apr; ():. PubMed ID: 38605655
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholinesterase inhibitors: a patent review (2008 - present).
Pohanka M
Expert Opin Ther Pat; 2012 Aug; 22(8):871-86. PubMed ID: 22768972
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of acetylcholinesterase and butyrylcholinesterase meet immunity.
Pohanka M
Int J Mol Sci; 2014 Jun; 15(6):9809-25. PubMed ID: 24893223
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cellular biology of cholinesterases.
Massoulié J; Pezzementi L; Bon S; Krejci E; Vallette FM
Prog Neurobiol; 1993 Jul; 41(1):31-91. PubMed ID: 8321908
[No Abstract] [Full Text] [Related]
8. Cholinesterases and the fine line between poison and remedy.
Pope CN; Brimijoin S
Biochem Pharmacol; 2018 Jul; 153():205-216. PubMed ID: 29409903
[TBL] [Abstract][Full Text] [Related]
9. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholinesterase inhibitors: pharmacology and toxicology.
Colović MB; Krstić DZ; Lazarević-Pašti TD; Bondžić AM; Vasić VM
Curr Neuropharmacol; 2013 May; 11(3):315-35. PubMed ID: 24179466
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease.
Shao ZQ
Int J Clin Exp Med; 2015; 8(2):2944-8. PubMed ID: 25932260
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.
Noetzli M; Eap CB
Clin Pharmacokinet; 2013 Apr; 52(4):225-41. PubMed ID: 23408070
[TBL] [Abstract][Full Text] [Related]
13. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes. Update 2014.
Froestl W; Muhs A; Pfeifer A
J Alzheimers Dis; 2014; 42(1):1-68. PubMed ID: 24903780
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
Singh M; Kaur M; Kukreja H; Chugh R; Silakari O; Singh D
Eur J Med Chem; 2013; 70():165-88. PubMed ID: 24148993
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase: C-terminal domains, molecular forms and functional localization.
Massoulié J; Anselmet A; Bon S; Krejci E; Legay C; Morel N; Simon S
J Physiol Paris; 1998; 92(3-4):183-90. PubMed ID: 9789805
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional structure of acetylcholinesterase and of its complexes with anticholinesterase drugs.
Sussman JL; Harel M; Silman I
Chem Biol Interact; 1993 Jun; 87(1-3):187-97. PubMed ID: 8343975
[TBL] [Abstract][Full Text] [Related]
17. Modes of attachment of acetylcholinesterase to the surface membrane.
Silman I; Futerman AH
Eur J Biochem; 1987 Dec; 170(1-2):11-22. PubMed ID: 3319614
[TBL] [Abstract][Full Text] [Related]
18. Diagnoses of Pathological States Based on Acetylcholinesterase and Butyrylcholinesterase.
Pohanka M
Curr Med Chem; 2020; 27(18):2994-3011. PubMed ID: 30706778
[TBL] [Abstract][Full Text] [Related]
19. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity.
Freier DO; Fuchs BA
J Pharmacol Exp Ther; 1994 Sep; 270(3):1127-33. PubMed ID: 7932161
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
